We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Application Provides Discovery, Collaboration, and Business Intelligence Tools

By MedImaging International staff writers
Posted on 05 Feb 2009
Print article
Zassi Medical Evolutions (Fernandina Beach, FL, USA) recently announced the launch of e-Zassi an online community, which provides powerful efficiencies to the medical device industry by streamlining diligence, collaboration, and discovery of new medical technologies and industry participants with an exclusive range of intelligent web-based applications.

In development for several years, e-Zassi.com has been designed to extract critical technical- and business-related traits and attributes from technologies, organizations, and individuals within the medical device-specific community. This "business DNA” can then be utilized to increase search/match relevancy and materially enhance success rates and lower costs.

E-Zassi's proprietary Deep DNA (Device Network Attributes) profiling technology captures in-depth and highly relevant search criteria on the proficiencies, preferences, and targeted areas for development of individuals and organizations. The company believes that allowing members to leverage these vital attributes to enable collaboration in the medical device sector will lower costs and create efficiencies; as these capabilities are not typically identified or utilized by existing broad, conventional business networks or search engines.

Available by subscription, e-Zassi members will have 24/7 access to a variety of modules including the world's first Innovation Assessment software platform. This platform allows members to deeply analyze and profile medical technologies via a simple to use question and answer process. Remarkably, the program utilizes no confidential information to generate powerful development and commercially related outputs that are critical to activities such as: technology transfer; business development; market and commercial analysis; due diligence; intellectual property and patent development; and product development and financial planning.

The company recognizes the value provided by the ability to gain insights earlier in the innovation, development, and financing decision process of a new product or technology. Knowledge in areas such as its clinical, regulatory, reimbursement, market, manufacturing, distribution, and sales requirements are critical in helping to ensure successful development and commercialization. The e-Zassi system provides this decision support knowledge in minutes providing great value to innovators, device manufacturers, service providers, venture capital firms, researchers and healthcare providers as they diligence, develop, fund, or provide services for medical technologies.

"The [US]$250 billion global medical device industry invests more than $40 billion annually in new product innovation and development alone. As such, it requires rapid decision-making, comprehensive planning, and increased efficiency in terms of technology due diligence, business networking, and strategic partnering. As veterans from the medical device space ourselves, we know traditional connectivity methods such as conventions, magazine advertising, and even the use of broad, non-medical device online networking sites are not really cost-effective and do not address the very specific technical and business requirements of our industry. We knew it was time to combine the latest in Cloud Computing technology with our powerful new DNA-based assessment and collaboration software platforms to create a vertical search engine dedicated to our specific device industry as existing general search engines are becoming flooded with too much noise,” stated Peter M. von Dyck, e-Zassi's founder and chief executive officer.

Related Links:

Zassi Medical Evolutions



Ultrasound Imaging System
P12 Elite
Silver Member
X-Ray QA Meter
T3 AD Pro
Digital Radiographic System
OMNERA 300M
X-ray Diagnostic System
FDX Visionary-A

Print article

Channels

Radiography

view channel
Image: The new machine algorithm can identify cardiovascular risk at the click of a button (Photo courtesy of Adobe Stock)

Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans

A new study published in the Journal of Bone and Mineral Research reveals that an automated machine learning program can predict the risk of cardiovascular events and falls or fractures by analyzing bone... Read more

MRI

view channel
Image: In brains of control mice (left) and PD mice (right), from bottom to top: neuronal activity in a representative animal (Photo courtesy of Ruxanda Lungu/FC)

Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable

Parkinson's disease (PD) remains a challenging condition to treat, with no known cure. Though therapies have improved over time, and ongoing research focuses on methods to slow or alter the disease’s progression,... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.